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Design sensitivity inobservationalstudies
BY PAUL R. ROSENBAUM
Statistics Department, Wharton School, University of Pennsylvania, Philadelphia,
Pennsylvania 19104-6340, U.S.A.
rosenbaum@stat.wharton.upenn.edu
SUMMARY
Outside the field of statistics, the literature on observational studies offers advice about
research designs or strategies for judging whether or not an association is causal, such as
multiple operationalism or a dose-response relationship. These useful suggestions are
typically informal and qualitative. A quantitative measure, design sensitivity, is proposed
formeasuring the contribution such strategies make in distinguishing causal effects from
hidden biases. Several common strategies are then evaluated in terms of their contribution
to design sensitivity. A related method for computing the power of a sensitivity analysis
is also developed.
Some key words: Pattern matching; Quasi-experiment;

Sensitivity analysis.

1. REDUCING SENSITIVITYBY DESIGN
1 1. How effective are common designsfor observational studies?
Several scientific fields offer useful advice about the design of observational or non
experimental studies of treatment effects. Obviously, the first step is to adjust for observed
covariates, to compare subjects who appear similar in terms of observed covariates prior
to treatment, but beyond that there is invariably the concern that subjects who appear
similar actually differ in terms of important unmeasured covariates. Much of the advice
about design aims to reduce the 'threat to validity' from unobserved covariates. Referring
to such studies as 'quasi-experiments', Cook et al. (1990, pp. 570-1) write that
the warrant for causal inferences from quasi-experiments rests [on] structural
elements of design other than random assignments-pretests, comparison groups, the
way treatments are scheduled across groups . .. -[which]
provide the best way of ruling
out threats to internal validity
... [C] onclusions
are more plausible if they are based on

evidence that corroborates numerous, complex, or numerically precise predictions drawn
from a descriptive causal hypothesis.'
For representative
Palmer (1959), Hill
advice is useful and
relative effectiveness
not easily clarified.

discussions of the design of observational studies, see Yerushalmy &
(1965), Susser (1987), Meyer (1995) and Shadish et al. (2002). This
widely used, but, because it is stated informally, the absolute and
of different strategies is not immediately apparent, and conflicts are

Here, a quantitativemeasure,design sensitivity,is developed for appraisingcompeting
strategiesin thedesignof observationalstudies.The design sensitivityis a quantity some
what akin to Pitman efficiency:it comparesthe relativeeffectivenessof competingdesigns
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for the same task in large samples. For a specific treatment effect and a specific research
design with a large sample size, the design sensitivity asks the question of how much
hidden bias would need to be present to render plausible the null hypothesis of no effect.
The answer is a number, and it provides a quantitative comparison of alternative research
designs. Other things being equal, we prefer the design that is less sensitive to hidden biases.
The design sensitivity is a general concept, defined in ? 3, following a brief review of
sensitivity analysis in ? 2. The design sensitivity is then used to appraise two common
design strategies, 'multiple operationalism' and the selection of treatment doses, which are
reviewed in ? 1 2. In ? 4, the effectiveness of these two strategies is appraised and compared,
and certain ostensibly conflicting claims about doses are shown, upon formalisation, to
refer to different situations without conflict. This is done in a simple setting that permits
exact evaluations, although the design sensitivity may be applied in other contexts as well.
The effect of finite sample size and the power of a sensitivity analysis are discussed in ? 5;
these results are useful in planning a specific study, rather than in comparing design
strategies.

1-2. Pattern specificity:Multiple outcomes and doses
'Succesful prediction of a complex pattern of multivariate results,' write Cook & Shadish
(1994, p. 565), 'often leaves few plausible alternative explanations.' Often, only certain
patterns are scientifically plausible as treatment effects (Weed & Hursting, 1998). Trochim
(1985, p. 580) writes that '. . .with more pattern specificity it is generally less likely that
plausible alternative explanations for the observed effect pattern will be forthcoming.' One
form of pattern specificity is 'multiple operationalism' or 'coherence' inwhich several out
comes should all be affected by the treatment in a known direction. Campbell (1988, p. 33)
writes that '... great inferential strength is added when each theoretical parameter is
exemplified in two or more ways, each mode being as independent as possible of the other,
as far as the theoretically irrelevant components are concerned'; see Reynolds & West
(1987) and Li et al. (2001) for examples.
Another form of pattern specificity concerns dose-response; see Hill (1965), Weiss (1981),
Susser (1987) and Rosenbaum (2003). Hill (1965, p. 298) writes that
'...

if the association

can reveal a biological
carefully for such evidence.

is one which

gradient, or dose-response
For instance, the fact that

look most
rate from cancer of the lung rises linearly with the number of cigarettes smoked
daily, adds a very great deal to the simpler evidence that cigarette smokers have a higher
death rate than non-smokers.'
curve,

then we should

the death

The available informal advice about dose-response relationships appears, at first, to be
in conflict. Hill (1965) stresses that a dose-response relationship is important for causal
inference. It is also said that observational studies should be patterned after simple experi
ments (Cochran, 1965). In experiments with human subjects, such as clinical trials, it is
typically said (Peto et al., 1976, p. 590) that one should compare just two treatments that
are as different as possible. Of course, these three bits of advice all seem reasonable, but
also appear to conflict. If there is just a high-dose group and a zero-dose control, then

the treatmentsare as different as possible, but there is no evidence about graduated
increasesin responsewith graduated increasesin dose. It turnsout however that,when
these bits of advice are formalised, they are each correct in a certain sense and not in
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conflict. Section 4 3 discusses the selection of doses during research design, whereas ? 4 4
discusses the rather different issue of the use in analysis of whatever doses happen to be
available.

2.

BRIEF

REVIEW

OF SENSITIVITY

2 1. Review: Modelfor

ANALYSIS

treatment assignment

Although design sensitivity may be computed for a wide variety of situations, tominimise
incidental technicalities, the general idea of ? 3 will be illustrated in the important special
case of matching with a fixed number k of controls, with k > 1. There are I matched
sets, i= 1, . . ., I, with one treated subject and k untreated controls in each matched set,
i = 1, . . ., k + 1, where the subscript (i,j) carries no information, and the treated subject
is identified by Zij = 1 and the controls by Zij = 0. The sets were matched for observed
covariates, but failed to control an unobserved covariate uij. In set i, the treatment is
,ZI,k+ 1)T,and write 0 for
applied at a nonnegative dose di > 0. Write Z = (Z11,Z12,...
the set containing the (1 + k)' possible values of Z, so that z EY implies that Zij is 1 or 0
and

1 =k+l

zij.

In a randomised experiment, one subject in each matched set would be randomly picked
for treatment, the others being assigned to control, with independent assignments in the
I distinct matched sets, so that pr (Zij= 1) = (k+ 1)-1, for each i,j. In the absence of
random assignment, subjects with different values of the unobserved covariate umay have
different chances of receiving the treatment. The sensitivity model assumes the following:
(i) in the population before matching, treatments were assigned independently, and two
subjects with the same value of the observed covariates used for matching may differ in
their odds of receiving the treatment, pr (Z = 1)/pr (Z = 0), by at most a factor of F > 1;
(ii) subjects were exactly matched in disjoint matched sets using just observed covariates
and the condition that each matched set contains one treated subject and k controls, so
that 1=
1 Zij for each i. It is straightforward to show (Rosenbaum, 1995; 2002, ? 4.2.2)
that this is exactly the same as assuming the following model, where y = log (F) > 0:
Z
pr (Z = z) = ftlk+
1
Pr(Zz)i=

ej=pu)
2exp
=
(yuij)

1

with 0 < uij < 1, for all i,j, for each z EY and for some unobserved covariate uij. For
discussion of unbounded uij, see Rosenbaum (1987, ? 4). If F = 1 or y = 0, then (1) is the
For F>1,
the distribution (1) is
randomisation distribution, pr(Z=z)=(l+k)-'.
are
a
a single significance
u's
of
inference,
unknown because the
unknown, so instead
single
level say, the result will be a range of significance levels, the range becoming wider as F
increases. How largemust F be, that is, how farmust (1) depart from the randomisation
distribution, to alter materially the conclusions of the study? This is the question addressed
by the sensitivity analysis.
2 2. Review: Bounds on inferencefor hidden biases of a given size
Each subject exhibits a p-dimensional response, Rij, with mth coordinate Rijm. Under
the null hypothesis of no treatment effect, the same value of Rij is observed whether the

subject is assigned to treatmentor control,whereas alternativehypotheses assert that
receivingthe treatmentchangesa subject'sobserved response.Let the scalarqi be some
formof rankof Rij For example,with a singleresponse,p= 1, a commondefinitionof the
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rank qij entails ranking separately within each matched set from 1 to k + 1. Pirne (1974)
argues for ranking separately in different matched sets. An alternative, still with p = 1,
aligns the responses within each matched set by subtracting their mean, Rij - Ril, where
Ril =(k+ l)-1 yk+ Rijl, and assigns ranks qij from 1 to I(k+ 1) to these aligned
responses; see Hodges & Lehmann (1962). With p > 2, one common strategy calculates
one of the two ranks just described from a univariate summary of Rij (Dawson & Lagakos,
1993), and an alternative computes ranks for coordinates first and combines the ranks
(O'Brien, 1984; Rosenbaum, 1991). Consider the statistic T= I= diL Zijqij. For
suitable k, di and qij, the statistic T can express a wide variety of multiple outcome
summary statistics, such as a sum of p stratified Wilcoxon rank sum statistics or aligned
rank statistics, a sum of p stratified Mantel & Haenszel (1959) statistics or Mantel (1963)
extension statistics, or the coherent signed rank statistic (Rosenbaum, 1997). For instance,
if the p responses are all binary, Rijm= 1 or Rijm= 0, and the doses are constant, di = 1,
statistics with qij =
then T is the sum of p correlated Mantel-Haenszel
=Rijm.
Sensitivity analyses for tests are inverted to yield confidence intervals and point estimates
(Rosenbaum, 2002, ??4-5) or multivariate equivalence tests (Li et al., 2001).
A one-sided test of the hypothesis of no treatment effect rejects when T is large, and
requires the computation of pr (T ) k) under the null hypothesis. Since the u's are not
observed, each F and each possible value of the I(k + 1) unobserved u's can yield a different
significance level, pr (T ) k), using (1). For several values of F, the sensitivity analysis
computes themaximum possible value of the significance level, pr (T >? k). For F = 1, there
is only one possible significance level, namely the usual one from the randomisation test.
For each fixed F > 1, there is an assignment of values to the I(k + 1) unobserved covariates
ui. which provides the maximum value of pr (T > k), and this maximum has either uij= 0
or uij = 1 for each i,j with at least one 0 and one 1 in each matched set (Rosenbaum
& Krieger, 1990). Gastwirth et al. (2000, ? 3) give an easily computed large-sample
Normal approximation to the maximum pr (T ) k) by setting the u's to yield the maxi
mum expectation yr of T, and, if several different patterns of u's produce the same
maximum expectation, then picking from among these the one yielding the largest
variance.
Gastwirth

set i.As shown
in
ranks for matched
qi(l) <s qi(2) -<. .. < qi(k+ 1)be the ordered
of Ek+1 Zijqij
et al. (2000, ? 341), in matched
set i, the largest null expectation

Let

under (1) is
K ~

max

ae{1

k}

Ej1qj(J)i+Lj=a+lqi(j)

a +F(k + 1-a

2

If themaximum in (2) is attained for each a EAi ' {1, . . . ,k}, then find the largest variance
of j+1 Zijqij among a's yielding this largest expectation,
2
vr=maAx

('

2
2

lqij()+FZj=a+lqj(J)
a+F(k+

(3)

1-a)

noting carefully that (3) is a maximum over Ai, not over {1, .. ., k}. For conventional
ranks, qi(l)= 1, ... qi(k+ 1)= k + 1, the required values of Kri and vi are tabled inGastwirth
et al. (2000, Table

1). To

avoid

degenerate

situations

as I -+ oo, it is convenient

< V <
that the v2 are uniformly bounded, that is 0 < V2min

to assume

for all i, as would auto

matically be true if conventional ranks 1, ... ., k? 1were used.Write jir
= Zdi}Kviand
isr themaximum variance
is themaximum expectation of T and
[n
dtve
, so that
ra= Z
of T among patterns of the ui that yield the maximum expectation. Proposition 1 of
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Gastwirth et al. (2000) shows that themaximum value of the upper tail probability under
the null hypothesis,

pr (T > k) for k > yr, converges

to 1-(

yr)/ar}

(k-

as I -* so, where

(D(.) is the standard Normal cumulative distribution, the approximation often being quite
good for I as small as 15.
Observational studies vary considerably in their sensitivity to hidden bias. Hammond's
study of heavy smoking as a cause of lung cancer is sensitive only to very large biases,
F = 6, whereas the study of Jick et al. on coffee as a cause of myocardial infarction is
sensitive to quite small biases, F = 13; see Rosenbaum (2002, ? 4). For several recent
applications of thismethod of sensitivity analysis, see Aakvik (2001), Li et al. (2001) and
Normand et al. (2001). Alternative methods of sensitivity analysis for hidden bias in
observational studies are discussed by Cornfield et al. (1959), Rosenbaum & Rubin (1983),
Gastwirth (1992), Copas & Li (1997), Lin et al. (1998), Robins et al. (1999), Copas &
Eguchi (2001) and Imbens (2003).
As I increases, it is somewhat more convenient to work with means rather than totals,
so write T1= T/I, ,rl = ur/I and r = va/I, so that the approximate bounding Normal
distribution for T1 has expectation ,ir and variance dr/I.
3. DESIGN

SENSITIVITY

The definition of 'design sensitivity' applies tomatching with one or more controls as in
? 2, and also to other situations inwhich the large-sample approximation to the sensitivity
bound is based on comparing a test statistic to a Normal distribution with expectation
lr and variance U2r
Let TI be asymptotically Normal so that
pr{II(TI
for each

fixed

k, as I -+ oo. In (4), ,u

and

> k}

1-(D(k)

cI2/I are

the actual

(4)
expectation

and

variance

of

the limiting distribution of TI in some situation. A large-sample statistical test of the null
hypothesis of no treatment effect compares T, not to its actual limiting distribution (4),
but rather to its limiting distribution under the null hypothesis, and, in parallel, a large
sample sensitivity analysis compares TI to its limiting bounding distribution, in typical cases
a Normal distribution with expectation fir and variance ar/I. For a fixed F, the approxi
mate upper bound on the one significance level is less than a if I2(TI - Pir)/r > ka,where
1= D(k.), and the chance that this happens satisfies
pr {(Ti

fir)

I
} = pr {TI(Ti-

{k

[)

kr

r+2I(firU

+ Pi (Pir-

)}

)}

which tends to 1 if fir< ,uand to 0 if fir>s,u.This says that,becausehidden biases are of
order 0(1), bias dominates the sensitivity analysis in large samples. The 'design sensitivity'

is thevalueof F which solvesflir= juSince (2) and f(irareexact,finite-sampleexpectations,
for thesituationin ? 2, theequationfir= ,u,and itssolution,F, involveonly exactmoments,
and do not directly use the Normal approximation.
In large samples, hidden bias can render the null hypothesis of no treatment effect

plausible if themagnitude of hidden bias,measured by F, is greater than the design
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sensitivity. If a first research design strategy has a larger design sensitivity than a second
design, then the first design is less sensitive to bias: larger biases would have to be present
to explain away the observed associations if the first design were used. Other things being
equal, we would prefer a design with a larger design sensitivity. It turns out that multiple
operationalism and doses affect the design sensitivity in ways that are quantified in ? 4.
Without hidden bias, F = 1, (5) approximates the power of a randomisation test for
fixed large I; see Noether (1987). For each F > 1, (5) approximates the probability that
the maximum significance level for this F will be at most oc;it is the analogue of power
for a sensitivity analysis. Power is discussed in ? 5.

4. USING DESIGN SENSITIVITYTO COMPAREDESIGNS
4 1. A simple case: Gaussian distributions and a Wilcoxon statistic
This section considers a simple situation that provides an informative and compre
hensive yet straightforward comparison. Along the lines of Dawson & Lagakos (1983), the
stratified rank sum statistic is applied to a linear summary measure, with doses and many
matched sets. The model for sensitivity analysis with hidden bias and no treatment effect
was given in ? 2, and it yields one component of the design sensitivity, namely -ir
= hr/I,
using conventional ranks qi(l)= 1, qi(2)= 2, .... qi(k+1)= k + 1 in (2). This is compared to
a model without hidden bias, F = 1, so that pr (Z = z) = (1 + k) -I, but with a treatment
effect. The model for the effect of the treatment on the p-variate response, Rij, has a
p-dimensional additive matched set parameter, oci,a p-dimensional slope parameter, ,3,an
effect on the treated Zij = 1 subject that is linear in the dose di with slope vector /3,and
independent and identically distributed p-variate continuously distributed errors, E-j;
that is, Rij = ci+ ZijBfdi+ Eij. A p-dimensional vector of weights, c, is selected, the scalar
summary cTRij is computed, these summaries are ranked from 1 to k + 1 in each matched
set, yielding qij, and the statistic T is computed; see Dawson & Lagakos (1993).
Let W4 be the difference between the CTRij for the one treated subject inmatched set i
and the CTRi for any one control subject in set i. In Wi, differencing has removed the
matched set parameter, oci,but has left behind the treatment effect cTfdi, together with
the difference of two independent errors cTEij. Now
'j=+Zijqij isWilcoxon's rank sum
statistic with one treated subject and k controls, so it equals 1 plus theMann-Whitney
statistic, defined as the count of the number of times the treated subject had a higher
cTRij than each of the k controls, so that Ek+2 Zij qij has expectation 1+ k pr(Wi > 0);
see Lehmann (1998, ? 1) for the relationship between Wilcoxon's
rank sum and the
statistic. It follows that
Mann-Whitney
1
4u=E(TI)=

di1 + k pr(Wi >O)}.

(6)

The design sensitivity F solves pr = ,u,and this depends on the distribution of error vectors
Eij only through pr(W > 0).
If the errors, Eij, are p-variate Normal, N(0, 1), then Wi isNormal with expectation
dicTf and variance 2cTXc. If we write bi for (dicT)/(2cTc) 2 it follows that pr (I > 0) is
f{3i1}. From this, it is straightforward to solve the equation II=i 5 for F to obtain the

design sensitivity.If the errorsE are not p-variateNormal, to calculate ,uone must
calculate the chance that a scalar random variable, W4', is positive. This is possible
analytically for some multivariate distributions, and it is always easily done by simulation.
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4 2. Calculating the design sensitivity: A numerical illustration
To illustrate the calculations, suppose the p-dimensional outcome isRi = ci+ Zipftdi+ Eij,
where Eij has p-variate Normal distribution with expectations equal to 0, variances equal
to 1 and constant intercorrelation p. Suppose c is a p-dimensional vector of l's, and the
vector ft has ft1=... = f,p, so that the responses are imperfectly correlated but have the
same relationship with the dose. There are three doses, di, namely 4 1 and 4, each occurring
in one-third

of matched

k=

sets. For

3 controls,

p = 3 outcomes

with

correlation

p =2

with each ftm=4 for di=4, 1 and 4, one calculates, respectively, pr (WI> 0) = 05857,
06675 and 07420, and then di{1 + k pr(W > O)} = 1P379, 3002 and 4839, yielding
p = (1P379+ 3 002 + 4-839)/3 = 3 073. Solving ,ir = 3 073 gives a design sensitivity of
F = 3 48. For comparison, with a single outcome, p = 1, and other quantities as before,
the design sensitivity is F = 2 82, so that the use of three outcomes has reduced sensitivity
to hidden bias by this magnitude.
4 3. Appraising common strategiesfor design
How effective are the suggestions in ? 1P2at reducing sensitivity to hidden bias? Table 1
offers some indications using the design sensitivity, F, as a measure. Table 1 allows the
sample size to increase without bound, I -+ oo, and asks about the magnitude of hidden
bias, F, that could explain away an observed treatment effect. The use of p = 1, 2 or 3
outcomes is considered, with equal correlations of p = 0 or p = 4. Three dose patterns are
considered. The pattern (1, 1,4) has three equally probable doses which average to 1; this
is the only pattern which produces a dose-response relationship. The pattern (1, 1, 1) has
constant dose 1. The pattern (4 ,4,) has constant dose 4. Comparison of (1, 1,4) and
(1, 1, 1) indicates the value of a dose-response relationship when the average dose is the
same, with or without a dose-response relationship. Comparison of (1, 1, 4) and (3434 3)
contrasts the idea that a dose-response relationship is important with the competing idea
that treatment and control should be as different as possible. There are k= 2 or k = 5
controls per matched set. In all cases, ft1= ... = ftp= 2, SOreceiving the treatment at dose 1
increases each expected response by one-half of a standard deviation.
In Table 1, the design strategies have a substantial impact on design sensitivity, which
ranges from F = 2 15 to F = 11 74, even though the effect of the treatment at dose di = 1
is constant throughout.

Table 1. Design sensitivityfor matched studies
with doses and p coherent outcomes
P=

P =0

Doses

p

k=2

(1, 1, 3)

1

240

2

330

3

417

(1, 1, 1)

1
2
3

(3, 3, )

1
2
3

k=2

k=5

297

240

297

456

271

349

6-40

286

375

215
2-86
355

258
375
505

215
239
2-51

258
297
316

303
462
637

406
748
1174

303
355
381

406
505
559

k=5
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To what extent does 'multiple operationalism' or coherence among several responses
reduce sensitivity to hidden bias? There is a substantial reduction in sensitivity to hidden
bias with p = 3 similarly affected outcomes when compared with p = 1 outcome providing
the outcomes have uncorrelated errors, p = 0, but the gains frommultiple outcomes, while
stillmeaningful, are reduced by an intermediate correlation, p = 4. For instance, with doses
(1, 4) and k = 5 controls, the design sensitivity is F = 640 with p = 3 unrelated but
equally affected outcomes, but falls to F = 3 75 for p = 3 outcomes with intercorrelation
P= 2
p

and

to F = 2 97 with
is of no value.

falls further

1, coherence

a single

outcome,

p=

1. Of

course,

in the limit as

Table 1 addresses two aspects of dose-response relationships. Consider first the com
parison of doses (4, 1, 4)with constant doses (1, 1, 1), so that the average dose for treated
subjects is 1 in both situations. In this comparison, a dose-response relationship does
reduce sensitivity to hidden bias; for instance, with k = 5 controls and p = 2 outcomes, the
design sensitivity with varied doses, (4, 1, 4), is F = 4 56, whereas with constant doses,
(1, 1, 1), it is F = 3-75. The gain from varied doses is often of meaningful magnitude, but
it is nonetheless one of the smaller sources of variation in Table 1.
The second aspect of dose-response relationships compares the varied doses (4, 1, 4)
with the fixed doses (4, 4, 4). This comparison asks whether it is better to make all of the
doses as far apart as possible or to vary the doses. Here, it is quite clear that it is better
to set the doses as far apart as possible rather than seek a dose-response relationship. For
instance, with k = 5 controls and p = 2 outcomes, the design sensitivity with varied doses,
(1, 1, 4), is F = 4 56, whereas with constant doses, (4, 4, 4), it is F = 7 48.
Recall from ? 1-2 that several bits of informal advice about doses appeared to conflict.
relationships tend to reduce sensitivity to hidden
Table 1 resolves this. Dose-response
bias when compared to studies with the same average but fixed dose, but setting the
doses further apart ismore valuable than varying the doses to display a dose-response
relationship. In observational studies, some practical approaches to setting doses further
apart are discussed in Rosenbaum (1999, ?? 3.3, 3.8). A matched sampling method for
picking pairs with similar covariates but very different doses is developed in Lu et al.
(2001, ? 2.5).

4 4. Using or ignoring available doses in analysis
In ? 4 3 the investigator could choose the doses during research design. Suppose instead
that doses simply happen to be available. Should the doses be used in analysis or ignored?
Not surprisingly, the conclusion of ? 4 3 is reversed: while it is better to collect data with
two widely separated doses, if the data have not been collected in this way, then the
analysis should use the doses that are available.
The statistic T =,=1di d
Zij qij uses the doses, attaching weight di to the rank
sum in a matched set in which the treated subject received dose di, whereas the statistic
T* YI=E
Zijqij ignores the doses that are present in the design, and is an
unweighted sum of the I rank sum statistics. Given that doses are present in the design,
how does the decision to use T or T* affect the design sensitivity?
The design sensitivity for T, using doses, is calculated as in ? 4 2, but the calculation

for T*, ignoringdoses, is slightly different.For T*, the doses do affect the responses
> 0), but they are ignored in the statistic
+ Ei and so affect pr (WN
Rij=xoci?ZLjf3di
ft
itself,which affectsboth and jir, and thereforeit affects the design sensitivity.If we
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continue the illustration in ? 4 2 with k = 3, p = 3, p = 2, common slope ,B= and doses
di=2, 1 and 4, the probabilities are pr (W1>0) = 05857, 0-6675 and 07420, as before.
Ignoring the doses using T* yields

[L= E {1+kpr(WV>0)}
which tends to 1+ (0 5857 + 0 6675 + 0 7420) = 2 9952, and solving 2'9952 = ,ir yields a
design sensitivity of F = 2 96, in contrast to F = 3 48 from ? 4 2 for T using doses.
In Table 2, the common slope is /=4, and doses di=4, 1 and 4 occur each with
probability 3. In all 12 situations in Table 2, using doses reduces sensitivity to hidden
bias compared to ignoring doses, and the gain is substantial in a few situations, such as

k= 5, p= 3 and p = 0, where thedesign sensitivityimprovesfromF = 4 80 to F = 6 4O.
Table 2. Design sensitivity using or ignoring
doses present in the design with p outcomes
=

p=o
k=2 k=5

k=2

k=5

p= 1

Use doses
Ignoredoses

2 40
2 13

2-97
2 56

2 40
2-13

2 97
2 56

p= 2

Use doses
Ignore doses

3230
2 81

4256
3 66

2471
2137

3249
2593

p= 3

Use doses
Ignore doses

4317
343

4640
480

2786
248

3475
3 11

Does the strength, ,B,of thedose-responserelationship
matter?Table 3 varies ,B= 1l, 4
and 1,with p= 1 outcome and k= 5 controls.Here, the treatmenteffect at dose di= 1
equals one-tenth of the standard deviation if ,t= onbut equals a full standard deviation
= 1.Of course, larger treatment effects, that is larger do's,yield lower design sensitivities
if ,B

for all designsandmethods of analysis.The qualitative impressionfromTables 1 and 2
is not changed by varyings:

when doses happen to vary, as in rows 1 and 3, there is some

improvementindesign sensitivityto be had by using thedoses in theanalysis,particularly
when the dose-response relationship is strong, = 1.Also, in rows 1 and 2, there is some
thing to be gained by varying the doses in the design when compared to giving all treated
subjects the same average dose again particularly when the dose-response relationship is

strong, ,B= 1.Equal doses that are larger,in row 4, are best of all.

Table 3. Doses in design versus doses in analysis: design
sensitivityefor four designs and analyses. (p = 1 outcome,

k= 5 controls)
Doses

Row
1
2

3
4

t

(s

in design

1,f)
(1, 1, 1)

(1,1, 3)
(3,3, 2)

Doses

in analysis

Used
Notsused

Not used
Not used

:=1

=

125
121

297
258

867
659

121
133

256
4 06

607
1577

/1=

1
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5. APPROXIMATE POWER FOR FIXED SAMPLE SIZES

The design sensitivity compared situations as the number of matched
without

bound,

I -s oo, and

it is a concise

of comparing

way

the relative

sets increased
performance

of

different design strategies. In planning a specific study, the sample size does matter, and,
based on (5), the 'power' of the sensitivity analysis for fixed, large I is considered in
this section.
Computing the approximate power of the sensitivity analysis (5) requires also the
variance U2/I of T1 under the alternative. Consider again the situation in ? 4. For con
ventional ranks, qi(l)= 1, ... , qi(k+ 1)= k + 1, T1 is theweighted average of IWilcoxon rank
sum statistics, so the expectation is (6), as before, where Wi is the random variable
W =

cT/3di

+

CT(Eij -

(j

Eij)

i').

Write W* = cT/3di+ CT(Eij- Eij )with j" tj' and j" tj; that is,WI and W* compare the
one treated subject, j say, inmatched set i to two different controls, j' and j", inmatched
> 0, W* > 0); then, by a standard result
set i.Write fi = pr (WI> 0) and hi = pr (WE
(Lehmann, 1998, p. 70, expression 2.21), the variance of T is
I
3 lkfi(1- f )+ k(k- 1)(hi - f )}
(72= ,
(7)
If, as in ? 4, the E's are N(0, X), then the (WI,W*)'s are bivariate Normal, where both
coordinates have expectation CTf#diand variance 2cT'c, and the covariance is cTXC.
Writing T(.,.) for the standard bivariate Normal distribution function with correlation 2
yields hi= T(i5, bi) with bi= (dicTf)/(2cTyc)2.
I = 200 matched sets and k = 3
=
As an illustration, consider a study with slopes I3m
controls per set, and a one-sided, 0-05 level test with doses used in analysis when doses
vary in design. If there is no hidden bias, F = 1, the power in all cases is nearly 1. Table 4
gives the approximate power of a sensitivity analysis for F = 2. The power is the chance
that 0 05 is greater than the upper bound on the p-value for F = 2. The general pattern
of the power in Table 4 for F = 2 is consistent with Table 1: larger constant doses (, 4, 4)
yield the highest power in Table 4, followed by varied doses (4, 14), followed by smaller
constant doses (1, 1, 1), and coherence among p = 3 outcomes increases power, although
the increase is smaller when the outcomes are correlated, p = 2. If the goal were to have
80% power in a sensitivity analysis with F = 2 when the effect is f3m= 1, then Table 4
indicates that some designs with I = 200 and k = 3 will achieve this goal while others
will not.

Table 4. Approximate power of the sensitivity
analysis for I = 200 matched sets with k = 3
controls, and p outcomes
Doses

p

p=?

p=42

(2 1, ) 1
(, 1, 3) 3

0-54
100

0-54
092

(1, 1, 1)

1

028

028

(1, 1, 1)

3

100

073

(2,2, ) 1 098 098
(2,2, 2) 3 1-00 1-00
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